LYMA Expands Its Revolutionary At-Home Skin Treatment in the U.S.

In a significant move to dominate the skincare at-home treatment market, LYMA, a pioneering British brand, has unveiled its plans for further expansion into the United States. The brand made waves last year with the launch of the LYMA Laser PRO, which has since attracted a loyal customer base and garnered recognition from prominent figures, including media personalities and beauty experts.

A Year of Record-Breaking Success

Following the introduction of the LYMA Laser PRO, the brand reported impressive growth, with revenues surging to $48 million in 2025. The product now represents over 70% of LYMA’s global sales, emphasizing the United States' vital role in the company’s strategy. Direct-to-consumer sales skyrocketed, tripling year-over-year in the first quarter of 2026, thereby solidifying LYMA’s reputation as a trailblazer in the skin health industry.

Continuing this success, LYMA is set to launch a dedicated U.S. website that promises seamless accessibility to customers with improvements like localized pricing, expedited delivery, and a dedicated concierge service catering to U.S. time zones. This site aims to alleviate concerns about foreign currency exchanges, ensuring a hassle-free shopping experience for American consumers.

New Partnerships and Enhanced Services

In a strategic partnership move, LYMA has joined forces with renowned retail chain Bloomingdale’s, expected to feature the LYMA Laser PRO this summer. Customers can take advantage of new payment plans, including flexible installment options and the possibility to use Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) for eligible purchases. This step signifies LYMA’s commitment to making advanced skincare technology accessible to an even wider audience.

Alongside these innovations, LYMA has made a significant addition to its leadership team by hiring its first U.S. Growth Officer, Nicole Fein. Her expertise will be pivotal as the company expands into the B2B sector, forging relationships with medical professionals, aesthetics practitioners, and spa owners across major cities, starting with New York.

Groundbreaking Clinical Evidence

LYMA's innovative approach is further bolstered by substantial clinical evidence. A landmark study published in the Aesthetic Surgery Journal Open Forum reveals groundbreaking results compared to traditional LED therapies. The LYMA Laser PRO has shown a 45-gene activation rate, including a notable six-fold increase in SIRT1, known as the longevity gene. This scientific validation elevates the device's status, proving its effectiveness beyond conventional at-home skincare solutions.

Accumulating accolades from industry leaders, celebrities, and users alike, LYMA has positioned itself firmly within a niche market that intersects beauty and health. Notable supporters of the device include actresses like Carey Mulligan and beauty experts like Bobbi Brown, highlighting its integration into the routines of high-profile individuals.

Furthermore, leading aesthetics professionals like Dr. Jason Diamond and Dr. Dendy Engleman have endorsed the technology, reinforcing its clinical integrity. Meanwhile, biohacker Dave Asprey has noted its importance in skin health optimization, suggesting that LYMA's influence reaches beyond just beauty into the realm of personal wellness and performance enhancement.

Looking Ahead

With its sights set firmly on expansion, LYMA's founder, Lucy Goff, expressed optimism about the future, stating, “What the year has delivered — in revenue, in clinical recognition, in the stories our customers and industry experts share with us — has surpassed even our most ambitious projections.” As LYMA continues to carve out its space in the U.S. market, the company aims to solidify its place as a leader in transformative skin care solutions, driven by innovative technology and a commitment to quality.

As LYMA continues to expand its reach and enhance its offerings, industry observers are eager to witness how this trailblazing brand will reshape the landscape of at-home skincare treatments in the increasingly competitive U.S. market.